Objective: Chromosome microarray analysis (CMA) and karyotyping are two important genetic testing techniques used in prenatal diagnosis. This study aims to evaluate the value of chromosome microarray ...

Introduction: Karyotyping and chromosome microarray analysis (CMA) are the two main prenatal diagnostic techniques currently used for genetic testing. We aimed to evaluate the value of chromosomal ...

#The script takes a list of CEL files from microarray Affymetrix platform and analyse them. #The script identifies the differential expressed terms with limma. #Enrichment analysis is carried out with ...

Abstract: Commercially developed microarrays, such as those from Agilent® and Affymetrix®, allow for the analysis of differential gene expression changes on a genome-wide scale. Publicly repositories ...

Almac and Affymetrix have signed an exclusive global distribution agreement allowing Affymetrix to sell Almac’s Xcel Array for biomarker discovery, development and delivery worldwide. The Xcel array ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) announced today that an international team of researchers led by scientists at Boston College, the Broad Institute, and Imperial ...

** For the processing pipeline for Affymetrix microarray data, GL-DPPD-7114.md, GeneLab has wrapped each step of the pipeline into a workflow with validation and verification of output files built in ...

Q2 loss $0.13/shr vs est loss $0.19/shr Q2 revenue $81.6 mln vs est of $77.1 mln Shares up 8 pct July 22 (Reuters) - Affymetrix Inc , which makes arrays to analyze genetic data, posted a quarterly ...

WASHINGTON, June 4 (Reuters) - A U.S. patent appeals court ruled on Thursday in favor of Agilent Technologies , which had been involved in a patent fight with Affymetrix Inc . The dispute was over ...